Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karin Sandager Nielsen is active.

Publication


Featured researches published by Karin Sandager Nielsen.


Molecular Pharmacology | 2006

Inhibitory Gating Modulation of Small Conductance Ca2+-Activated K+ Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons

Dorte Strøbæk; Charlotte Hougaard; Tina Holm Johansen; Ulrik Svane Sørensen; Elsebet Ø. Nielsen; Karin Sandager Nielsen; Ruth D.T. Taylor; Paola Pedarzani; Palle Christophersen

SK channels are small conductance Ca2+-activated K+ channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts extracellularly by a pore-blocking mechanism. 1-Ethyl-2-benzimidazolinone (1-EBIO) and 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) have been identified as positive gating modulators that increase the apparent Ca2+ sensitivity of SK channels. In the present study, we describe inhibitory gating modulation as a novel principle for selective inhibition of SK channels. In wholecell patch-clamp experiments, the compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3) with potencies around 100 nM. However, in contrast to known pore blockers, NS8593 did not inhibit 125I-apamin binding. Using excised patches, it was demonstrated that NS8593 decreased the Ca2+ sensitivity by shifting the activation curve for Ca2+ to the right, only slightly affecting the maximal Ca2+-activated SK current. NS8593 inhibited all the SK1-3 subtypes Ca2+-dependently (Kd = 0.42, 0.60, and 0.73 μM, respectively, at 0.5 μM Ca2+), whereas the compound did not affect the Ca2+-activated K+ channels of intermediate and large conductance (hIK and hBK channels, respectively). The site of action was accessible from both sides of the membrane, and the NS8593-mediated inhibition was prevented in the presence of a high concentration of the positive modulator NS309. NS8593 was further tested on mouse CA1 neurons in hippocampal slices and shown to inhibit the apaminand tubocurarine-sensitive SK-mediated afterhyperpolarizing current, at a concentration of 3 μM.


European Journal of Pharmacology | 1997

Class I mGlu receptor antagonist 1-aminoindan-1,5-dicarboxylic acid blocks contextual but not cue conditioning in rats

Karin Sandager Nielsen; Euan M. Macphail; Gernot Riedel

It is widely believed that metabotropic glutamate (mGlu) receptors play a potential role in memory formation. However, the particular function of different classes of mGluRs, or even subtypes, remains elusive. We show here that intraperitoneal injection of the class I selective antagonist 1-aminoindan-1,5-dicarboxylic acid (AIDA) in concentrations of 0.18 or 1.8 mg/kg 25 min prior to acquisition training blocks hippocampus-dependent contextual, but not hippocampus-independent cue, conditioning in rats. These data provide the first evidence for a specific role of mGlu receptors, class I in particular, in hippocampus-dependent learning tasks.


Archive | 2006

Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels

Ulrik Svane Sørensen; Lene Teuber; Dan Peters; Dorte Strøbæk; Tina Holm Johansen; Karin Sandager Nielsen; Palle Christophersen


European Journal of Pharmacology | 2013

Characterization of a novel high-potency positive modulator of Kv7 channels

William Dalby-Brown; Carsten Jessen; Charlotte Hougaard; Marianne L. Jensen; Thomas A. Jacobsen; Karin Sandager Nielsen; Helle K. Erichsen; Morten Grunnet; Philip K. Ahring; Palle Christophersen; Dorte Strøbæk; Susanne Jørgensen


Archive | 2009

NOVEL QUINOLINYLAMIDE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS

Dan Peters; Lars Christian B. Rønn; Karin Sandager Nielsen; Jørgen Scheel-Krüger


Archive | 2009

NOVEL ARYL PIPERAZINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS

Dan Peters; Lars Christian B. Rønn; Karin Sandager Nielsen; Jørgen Scheel-Krüger


Archive | 2007

Benzothiazine derivatives, their preparation and use

Alex Haahr Gouliaev; Morgens Larsen; Thomas Varming; Claus Mathiesen; Tina Holm Johansen; Karin Sandager Nielsen; Barbara P. Hartz; Jørgen Scheel-Krüger


Archive | 2007

Dérivés d'arylpipérazine utiles pour le traitement de troubles neuropsychiatriques

Giuseppe Campiani; Stefania Butini; Caterina Fattorusso; Silvia Franceschini; Zia Irene Thale; Karin Sandager Nielsen; Jørgen Scheel-Krüger; Lars Siim Madsen


Archive | 2006

Nouveaux derives de 2-(phenylamino)benzimidazole et utilisation de ceux-ci en tant que modulateurs de canaux de potassium actives par le calcium a faible conductance

Ulrik Svane Sørensen; Lene Teuber; Dan Peters; Dorte Strøbæk; Tina Holm Johansen; Karin Sandager Nielsen; Palle Christophersen


Archive | 2006

New 2-amino-benzimidazole derivatives and their use calcium-activated potassium channels as modulators with low conductivity

Ulrik Svane Soerensen; Lene Teuber; Dan Peters; Dorte Stroebak; Tina Holm Johansen; Karin Sandager Nielsen; Palle Christophersen

Collaboration


Dive into the Karin Sandager Nielsen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge